The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Heat Shock Protein 70 Induced During Tumor Cell Killing Induces Th1 Cytokines and Targets Immature Dendritic Cell Precursors to Enhance Antigen Uptake
Abstract
Previously, we reported that killing tumor cells in vivo with the HSV thymidine kinase/ganciclovir system generates potent antitumor immunity, determined in part by the mechanism by which the cells die and by the levels of inducible heat shock protein (hsp) expression induced during the process of cell death. Here, we show that induction of hsp70 expression induces an infiltrate of T cells, macrophages, and predominantly dendritic cells (DCs) into the tumors as well as an intratumoral profile of Th1 cytokine expression (IFN-γ, TNF-α, and IL-12) and enhances immunogenicity via a T cell-mediated mechanism. In addition, the protection conferred by hsp70 is both tumor and cell specific. We also demonstrate that hsp70 targets immature APC to make them significantly more able to capture Ags. This is likely to optimize cross-priming of the infiltrating APC with tumor Ags, which are simultaneously being released by the dying cells. In addition, using an Myc epitope-tagged hsp70 expression vector, we present evidence that hsp70 released from dying tumor cells is taken up directly into DCs and may, therefore, be involved in direct chaperoning of Ags into DCs. Taken together, our data suggest that hsp70 induction serves to signal the immune system of the presence of an immunologically relevant (dangerous) situation against which an immune reaction should be raised.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Practical Statistics for Medical Research.
Walter, S. D., & Altman, D. G. (1992) · Biometrics · doi:10.2307/2532320 · Cited by 11,668
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,820
Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., & Steinman, R. M. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1693 · Cited by 3,738
Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V, Hamada, H., Pardoll, D., & Mulligan, R. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3539 · Cited by 2,818
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
Albert, M. L., Sauter, B., & Bhardwaj, N. (1998) · Nature · doi:10.1038/32183 · Cited by 2,349
Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens
Huang, A. Y. C., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D., & Levitsky, H. (1994) · Science · doi:10.1126/science.7513904 · Cited by 1,160
Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules.
Shen, Z., Reznikoff, G., Dranoff, G., & Rock, K. L. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.6.2723 · Cited by 846
Human tumor antigens recognized by T lymphocytes.
Boon, T., & van der Bruggen, P. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.725 · Cited by 842
A Mechanism for the Specific Immunogenicity of Heat Shock Protein-Chaperoned Peptides
Suto, R., & Srivastava, P. K. (1995) · Science · doi:10.1126/science.7545313 · Cited by 823
Matzinger, P. (1998) · Seminars in Immunology · doi:10.1006/smim.1998.0143 · Cited by 748
Immunotherapy of Tumors with Autologous Tumor-Derived Heat Shock Protein Preparations
Tamura, Y., Peng, P., Liu, K., Daou, M., & Srivastava, P. K. (1997) · Science · doi:10.1126/science.278.5335.117 · Cited by 680
Heat shock proteins transfer peptides during antigen processing and CTL priming
Srivastava, P., Udono, H., Blachere, N., & Li, Z. (1994) · Immunogenetics · doi:10.1007/bf00188611 · Cited by 569
Heat Shock Proteins Come of Age: Primitive Functions Acquire New Roles in an Adaptive World
Srivastava, P. K., Menoret, A., Basu, S., Binder, R. J., & McQuade, K. L. (1998) · Immunity · doi:10.1016/s1074-7613(00)80570-1 · Cited by 540
Melcher, A., Todryk, S., Hardwick, N., Ford, M., Jacobson, M., & Vile, R. G. (1998) · Nature Medicine · doi:10.1038/nm0598-581 · Cited by 445
Self-citationCancer antigens: immune recognition of self and altered self.
Houghton, A. N. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.1 · Cited by 420
Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells
Multhoff, G., Botzler, C., Jennen, L., Schmidt, J., Ellwart, J., & Issels, R. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.9.4341 · Cited by 387
Regression of established macroscopic liver metastases after in situ transduction of a suicide gene.
Caruso, M., Panis, Y. H., Gagandeep, S., Houssin, D. P., Salzmann, J. L., & Klatzmann, D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.7024 · Cited by 370
Paracrine Cytokine Adjuvants in Cancer Immunotherapy
Pardoll, D. M. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.399 · Cited by 369
Udono, H., Levey, D. L., & Srivastava, P. K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3077 · Cited by 347
Arnold, D., Faath, S., Rammensee, H., & Schild, H. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.885 · Cited by 330
Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion
Finkelman, F. D., Lees, A., Birnbaum, R., Gause, W. C., & Morris, S. C. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.4.1406 · Cited by 319
Barba, D., Hardin, J., Sadelain, M., & Gage, F. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4348 · Cited by 297
Is cancer dangerous to the immune system?
Fuchs, E. J., & Matzinger, P. (1996) · Seminars in Immunology · doi:10.1006/smim.1996.0035 · Cited by 289
Suzue, K., Zhou, X., Eisen, H. N., & Young, R. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13146 · Cited by 250
Mullen, C. A., Coale, M. M., Lowe, R., & Blaese, R. M. (1994) · PubMed · Cited by 223
Vile, R. G., Castleden, S., Marshall, J. F., Camplejohn, R. S., Upton, C., & Chong, H. (1997) · International Journal of Cancer · Cited by 205
Self-citationIn vivo priming of two distinct antitumor effector populations: the role of MHC class I expression.
Levitsky, H. I., Lazenby, A., Hayashi, R. J., & Pardoll, D. M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1215 · Cited by 189
In vitro and in vivo targeting of gene expression to melanoma cells.
Vile, R. G., & Hart, I. R. (1993) · PubMed · Cited by 185
Self-citationColombo, M. P., Modesti, A., Parmiani, G., & Forni, G. (1992) · PubMed · Cited by 181
Self-citationImmune system in suicide-gene therapy
Freeman, S. M., Ramesh, R., & Marrogi, A. J. (1997) · The Lancet · doi:10.1016/s0140-6736(97)22001-5 · Cited by 143
Heat shock protein-peptide complexes in cancer immunotherapy
Srivastava, P. K., & Udono, H. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90076-0 · Cited by 139
Immunotherapy of Malignancy by In Vivo Gene Transfer into Tumors
Nabel, G. J., Chang, A. E., Nabel, E. G., Plautz, G. E., Fox, B. A., Huang, L., & Shu, S. (1992) · Human Gene Therapy · doi:10.1089/hum.1992.3.4-399 · Cited by 114
Hsp72-mediated augmentation of MHC class I surface expression and endogenous antigen presentation
Wells, A. (1998) · International Immunology · doi:10.1093/intimm/10.5.609 · Cited by 111
Self heat shock and gamma delta T-cell reactivity.
Rajasekar, R., Sim, G. K., & Augustin, A. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1767 · Cited by 99
Mitchell, D. A., Nair, S. K., & Gilboa, E. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199806)28:06<1923::aid-immu1923>3.0.co;2-9 · Cited by 92
Influence of gene-modified (IL-7, IL-4, and B7) tumor cell vaccines on tumor antigen presentation
Cayeux, S., Richter, G., Noffz, G., Dörken, B., & Blankenstein, T. J. F. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.6.2834 · Cited by 87
Can Co‐stimulated Tumor Immunity be Therapeutically Efficacious?
Hellströum, K. E., Hellström, I., & Chen, L. (1995) · Immunological Reviews · doi:10.1111/j.1600-065x.1995.tb00079.x · Cited by 76
Rodolfo, M., Zilocchi, C., Melani, C. C., Cappetti, B., Arioli, I., Parmiani, G., & Colombo, M. P. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.12.5536 · Cited by 65
Self-citation
Cited by
Immunobiology of Dendritic Cells
Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.-J., Pulendran, B., & Palucka, K. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.767 · Cited by 6,634
Photodynamic therapy and anti-tumour immunity
Castano, A. P., Mroz, P., & Hamblin, M. R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1894 · Cited by 2,676
Asea, A., Kraeft, S.-K., Kurt-Jones, E. A., Stevenson, M. A., Chen, L. B., Finberg, R. W., Koo, G. C., & Calderwood, S. K. (2000) · Nature Medicine · doi:10.1038/74697 · Cited by 1,620
Novel Signal Transduction Pathway Utilized by Extracellular HSP70
Asea, A., Rehli, M., Kabingu, E., Boch, J. A., Baré, O., Auron, P. E., Stevenson, M. A., & Calderwood, S. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200497200 · Cited by 1,510
Kregel, K. C. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01267.2001 · Cited by 1,455
Metadata
- Authors
- Todryk, S., Melcher, A. A., Hardwick, N., Linardakis, E., Bateman, A., Colombo, M. P., Stoppacciaro, A., & Vile, R. G.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-08-01
- Volume
- 163
- Issue
- 3
- Pages
- 1398-1408
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2117910086
- Cited by
- 328
- References
- 39
- FWCI
- 8.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.